Cover Image
市場調查報告書

腫瘤分子診斷的全球市場:2015年∼2019年

Global Oncology Molecular Diagnostics Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 338874
出版日期 內容資訊 英文 63 Pages
訂單完成後即時交付
價格
Back to Top
腫瘤分子診斷的全球市場:2015年∼2019年 Global Oncology Molecular Diagnostics Market 2015-2019
出版日期: 2015年09月02日 內容資訊: 英文 63 Pages
簡介

全球腫瘤分子診斷市場,預計2014年∼2019年以17.8%的年複合成長率成長。

本報告提供全球腫瘤分子診斷市場相關調查分析、市場規模與成長率、市場趨勢、市場的推動要素與課題、市場機會驗證、主要供應商等相關的系統性資訊。

第1章 摘要整理

  • 焦點

第2章 調查範圍

  • 市場概要
  • 主要供應商產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

  • 主要市場焦點

第5章 癌症統計

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 償付與適用範圍:概要

第8章 分子診斷產品:價格方案

第9章 市場區隔:癌症的各類型

  • 乳癌
  • 大腸癌症
  • 前列腺癌症
  • 其他癌症

第10章 地理區分

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第11章 推動市場成長要素

第12章 推動因素的影響

第13章 市場課題

第14章 推動因素與課題的影響

第15章 市場趨勢

第16章 業者情勢

  • 競爭模式
  • 市場佔有率分析
  • 其他卓越供應商

第17章 主要供應商分析

  • Abbott Diagnostics
  • Becton, Dickinson
  • Qiagen

第18章 關於Technavio

圖表

目錄
Product Code: IRTNTR6999

About oncology molecular diagnostics

Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing.

Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.

Technavio's analysts forecast the global oncology molecular diagnostics market to grow at a CAGR of 17.8% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global oncology molecular diagnostics market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of diagnostics assay kits and instruments for cancers, which include:

  • Breast
  • Colorectal
  • Prostate
  • Others (including lung and cervical cancers)

Technavio's report, Global Oncology Molecular Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • APAC
  • Europe
  • Latin America
  • MEA
  • North America

Key vendors

  • Abbott Diagnostics
  • Becton, Dickinson and Company
  • QIAGEN
  • Roche Diagnostics

Other Prominent Vendors

  • Agendia
  • Angsana Molecular and Diagnostics
  • Asuragen
  • Autogenomics
  • Beckman Coulter
  • bioMerieux
  • bioTheranostics (Formerly AviaraDx)
  • Cangen Biotechnologies
  • Cepheid
  • Diagnocure
  • Epigenomics
  • Eragen
  • EXACT Sciences
  • Exiqon
  • GeneNews
  • Genera Biosystems
  • Genomic Health
  • Genomix Biotech
  • Health Discovery
  • HTG Molecular
  • Hologic
  • Innogenetics
  • Intergenetics
  • Kreatech Holding
  • Myriad Genetics
  • Nanosphere
  • NorDiag
  • Nuvera Biosciences
  • OncoMethylome Sciences
  • Orion Genomics
  • Prediction Sciences
  • Predictive Biosciences
  • Rosetta Genomics
  • SensiGen
  • Source MDx
  • Vermillion

Market driver

  • Increase in demand for personalized medicines
  • For a full, detailed list, view our report

Market challenge

  • Ethical, privacy, and practical issues
  • For a full, detailed list, view our report

Market trend

  • Advances in mass spectrometry
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Cancer statistics

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Reimbursement and coverage: An overview

PART 08: Molecular diagnostic products: Pricing scenario

PART 09: Market segmentation by cancer type

  • Breast cancer
  • Colorectal cancer
  • Prostate cancer
  • Other cancers

PART 10: Geographical segmentation

  • Oncology molecular diagnostics market in Americas
  • Oncology molecular diagnostics market in EMEA
  • Oncology molecular diagnostics market in APAC

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 17: Key vendor analysis

  • Abbott Diagnostics
  • Becton, Dickinson
  • Qiagen

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Snapshot of global oncology molecular diagnostics market 2015-2019
  • Exhibit 03: Prevalent cancers worldwide 2012
  • Exhibit 04: Countries with highest cancer rates 2012
  • Exhibit 05: Cancer by gender 2012
  • Exhibit 06: Global oncology molecular diagnostics market 2014-2019 ($ billions)
  • Exhibit 07: Five forces analysis
  • Exhibit 08: Reimbursement perspectives of healthcare entities
  • Exhibit 09: Factors influencing price of molecular diagnostic products
  • Exhibit 10: Global oncology molecular diagnostics market segmentation by cancer type
  • Exhibit 11: Global oncology molecular diagnostics market segmentation by cancer type 2014
  • Exhibit 12: Global oncology molecular diagnostics market by cancer type 2014 ($ millions)
  • Exhibit 13: Global oncology molecular diagnostics market segmentation by geography 2014
  • Exhibit 14: Global oncology molecular diagnostics market segmentation by geography 2019
  • Exhibit 15: Global oncology molecular diagnostics market by geography 2014-2019
  • Exhibit 16: Oncology molecular diagnostics market in Americas 2014-2019 ($ millions)
  • Exhibit 17: Oncology molecular diagnostics market in EMEA 2014-2019 ($ millions)
  • Exhibit 18: Oncology molecular diagnostics market in APAC 2014-2019 ($ millions)
  • Exhibit 19: Impact of drivers
  • Exhibit 20: Impact of drivers and challenges
  • Exhibit 21: Abbott: Key takeaways
  • Exhibit 22: Becton, Dickinson: Key takeaways
  • Exhibit 23: Qiagen: Key takeaways
  • Exhibit 24: Roche Diagnostics: Key takeaways
  • Exhibit 25: Abbott Diagnostics: Key business offerings
  • Exhibit 26: Becton, Dickinson: Business segmentation by revenue 2014
  • Exhibit 27: Becton, Dickinson: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 28: Becton, Dickinson: Geographical segmentation by revenue 2014
  • Exhibit 29: Segmentation of Qiagen's business by revenues 2014
Back to Top